首页> 外国专利> Intrathecal and Intravenous Combination Gene Therapy for the Treatment of Infant Batten's Disease

Intrathecal and Intravenous Combination Gene Therapy for the Treatment of Infant Batten's Disease

机译:鞘内和静脉注射联合基因治疗婴儿巴顿病

摘要

A method of treating IBD or an IBD-associated disorder in a subject in need thereof, comprising the steps of combining intrathecal administration of a polynucleotide comprising a CLN1 open reading frame with intravenous administration of said polynucleotide. method to include. The polynucleotide comprising the CLN1 open reading frame is a wild-type CLN1 polynucleotide. In another embodiment, a polynucleotide comprising the CLN1 open reading frame comprises a codon optimized polynucleotide sequence of the polynucleotide or a complement thereof and is codon optimized for expression in a human cell.
机译:一种治疗需要的受试者的IBD或IBD相关疾病的方法,包括鞘内注射包含CLN1开放阅读框的多核苷酸与静脉注射所述多核苷酸相结合的步骤。方法包括。包含CLN1开放阅读框的多核苷酸是野生型CLN1多核苷酸。在另一个实施例中,包含CLN1开放阅读框的多核苷酸包含该多核苷酸或其补体的密码子优化的多核苷酸序列,并且是为在人类细胞中表达而优化的密码子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号